Sleep and quality of life in Parkinson's disease

Sleep and Quality of Life in Clinical Medicine

Volumn , Issue , 2008, Pages 175-185

  Whitehead, Daisy L ^a   Mitchell Hay, Rosalind ^b   Reddy, Prashant ^b   Muzerengi, Sharon ^b   Chaudhuri, K Ray ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

excessive daytime sleepiness (EDS); Parkinson's disease; quality of life; REM behaviour disorder; restless legs; sleep; sleep attacks; speriodic leg movements of sleep (PLMS)

Indexed keywords

EID: 77951825010     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-60327-343-5_20     Document Type: Chapter

References (94)

1. Chaudhuri KR, Healy DG, Schapira AHV. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5:235-45.
2. Pal PK, Calne S, Samii A, Fleming JAE. A review of normal sleep and its disturbances in Parkinson's disease. Parkinsonism Relat Disord 1999;5:1-17.
3. Chaudhuri KR, Martinez-Martin P, Schapira AHV, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study. Mov Disord 2006;21: 916-23.
4. Garcia-Borreguero D, Larrosa O, Bravo M. Parkinson's disease and sleep. Sleep Med Rev 2003;7:115-29.
5. Dhawan V, Healy DG, Pal S, Chaudhuri KR. Sleep-related problems of Parkinson's disease. Age Ageing 2006;35:220-8.
6. Tandberg E, Larsen JP, Karlsen K. A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord 1998;13:895-9.
7. Chaudhuri KR, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, Pezzela FR, Forbes A, Hogl B, Trenkwalder C. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatr 2002;73:629-35.
8. Chaudhuri KR, Schapira AHV, Martinez-Martin P, et al. The holistic management of Parkinson's using a novel non motor symptom scale and questionnaire. Adv Clinc Neurosci Rehab 2004;4:20-4.
9. Lees A, Blackburn N, Cambell V. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 1988;11:512-9.
10. Stocchi F, Brusa L, Vacca L, De PandisMF, Grassini P, Berardelli A, Ruggieri S. Sleep disturbances in Parkinson's disease. Eur J Neurol 2000;7:21-5.
11. Chaudhuri KR, Martinez-Martin P. Clinical assessment of nocturnal disability in Parkinson's disease -The Parkinson's disease sleep scale. Neurology 2004;63:S17-20.
12. Happe S, Kungel M, Rink P, Ebrecht M, Modell S, Trenkwalder C. Effects of controlled-release L-DOPA (NACOM R Retard/Sinemet TM CR) on sleep, motor fluctuations and quality of life in patients with Parkinson's disease. Mov Disord 2004;19:S273-4.
13. Ghatani T, Agapito C, Bhattacharya KF, Clough C, Chaudhuri KR. Comparative audit of pergolide and cabergoline therapy in the treatment of nocturnal 'off' periods causing sleep disruption in Parkinson's disease. Eur J Neurol 2001;8:8-11.
14. Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord 1999;14:922-7.
15. Merello M, Hughes A, Colosimo C, Hoffman M, Starkstein S, Leiguarda R. Sleep benefit in Parkinson's disease. Mov Disord 1997;12:506-8.
16. Atassi F, Vuong KD, Jankovic J, Ondo WG. The prevalence of restless legs syndrome in patients with Parkinson's disease. Neurology 2001;56:A21.
17. Dhawan V, Chaudhuri K R. Restless legs syndrome and Parkinson's disease. In Restless Legs Syndrome. Edited by WG Ondo. Informa Healthcare USA Inc: NY, 2007, pp. 247-54.
18. Tan EK, Lum SY, Wong MC. Restless legs syndrome in Parkinson's disease. J Neurol Sci 2002;196:33-6.
19. Kushida CA, Littner MR, Morgenthaler T, et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005;28:499-521.
20. Oerlemans WGH, de Weerd AW. The prevalence of sleep disorders in patients with parkinson's disease. A self-reported, community-based survey. Sleep Med 2002;3:147-9.
21. Andersen JT. Disturbances of bladder and urethral function in Parkinson's disease. Int Urol Nephrol 1985;17:35-41.
22. Trenkwalder C. Sleep dysfunction in Parkinson's disease. Clin Neurosci 1998;5:107-14.
23. Comella CL, Tanner CM, Ristanovic RK. Polysomnographic sleep measures in Parkinsons-disease patients with treatmentinduced hallucinations. Ann Neurol 1993;34:710-4.
24. Diederich NJ, Vaillant M, Mancuso G, Lyen P, Tiete J. Progressive sleep 'destructuring' in Parkinson's disease. A polysomnographic study in 46 patients. Sleep Med 2005;6:313-8.
25. Happe S, Klosch G, Lorenzo J, et al. Perception of sleep: Subjective versus objective sleep parameters in patients with Parkinson's disease in comparison with healthy elderly controls. J Neurol 2005;252:936-43.
26. Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep disorders and sleep effect in Parkinson's disease. Mov Disord 1990;5:280-5.
27. Menza MA, Rosen RC. Sleep in Parkinson's disease: the role of depression and Anxiety. Psychosomatics 1995;36:262-6.
28. Saper CB, Cano G, Scammell TE. Homeostatic, circadian, and emotional regulation of sleep. J Comp Neurol 2005;493:92-8.
29. Gjerstad MD, Aarsland D, Larsen JP. Development of daytime somnolence over time in Parkinson's disease. Neurology 2002; 58:1544-6.
30. Rye DB, Bliwise DL, Dihenia B, Gurecki P. Daytime sleepiness in Parkinson's disease. J Sleep Res 2000;9:63-9.
31. Ghorayeb I, Loundou A, Auquier P, Bioulac B, Tison F. A nationwide survey of excessive daytime sleepiness in ambulatory patients with Parkinson's disease in France. Mov Disord 2006;21:S542.
32. Whitney CW, Enright PL, Newman AB, Bonekat W, Foley D, Quan SF. Correlates of daytime sleepiness in 4578 elderly persons: the cardiovascular health study. Sleep 1998;21: 27-36.
33. Ghorayeb I, Yekhlef F, Chrysostome V, Balestre E, Bioulac B, Tison F. Sleep disorders and their determinants in multiple system atrophy. J Neurol Neurosurg Psychiatr 2002;72:798-800.
34. Meindorfner C, Korner Y, Moller JC, Stiasny-Kolster K, Oertel GH, Kruger HP. Driving in Parkinson's disease: mobility, accidents, and sudden onset of sleep at the wheel. Mov Disord 2005;20:832-42.
35. Tan EK, Lum SY, Fook-Chong SMC, Teoh ML, Yih Y, Tan L, Tan A, Wong MC. Evaluation of somnolence in Parkinson's disease: comparison with age and sex-matched controls. Neurology 2002;58:465-8.
36. Merino-Andreu M, Arnulf I, Konofal E, Derenne JP, Agid Y. Unawareness of naps in Parkinson's disease and in disorders with excessive daytime sleepiness. Neurology 2003;60:1553-4.
37. Schenck C, Bundlie S, Ettinger M, Mahowald M. Chronic behavioural disorders of human REM sleep: a category of parasomnia. Sleep 1986;9:293-308.
38. Boeve B, Silber MH, Parisi JE, et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 2003;61:40-5.
39. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 1996;46:388-93.
40. Gagnon JF, Bedard MA, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 2002;59:585-9.
41. Comella CL, Nardine TM, Diederich NJ, Stebbins GT. Sleeprelated violence, injury, and REM sleep behavior disorder in Parkinson's disease. Neurology 1998;51:526-9.
42. Scaglione C, Vignatelli L, Plazzi G, et al. REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study. Neurol Sci 2005;25:316-21.
43. De Cock VC, Vidailhet M, Leu S, et al. Restoration of normal motor control in Parkinson's disease during REM sleep. Brain 2007;130:450-6.
44. Diederich NJ, Vaillant M, Leischen M, Mancuso G, Golinval S, Nati R, Schlesser M. Sleep apnea syndrome in Parkinson's disease. A case-control study in 49 patients. Mov Disord 2005;20:1413-8.
45. Braga-Neto P, da Silva FP, Monte FS, de Bruin PFC, de Bruin VMS. Snoring and excessive daytime sleepiness in Parkinson's disease. J Neurol Sci 2004;217:41-5.
46. Sharf B, Moskovitz C, Lupton MD, Klawans HL. Dream phenomena induced by chronic levodopa therapy. J Neural Transm 1978;43:143-51.
47. Moskovitz C, Moses H, III, Klawans HL. Levodopainduced psychosis: a kindling phenomenon. Am J Psychiatry 1978;135:669-75.
48. Fenelon G, Mahieux F, Huon R, Ziegler M. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 2000;123(Pt 4):733-45.
49. Manni R, Pacchetti C, Terzaghi M, Sartori I, Zangaglia R, Nappi G. Sleep-wake cycle and visual hallucinations in Parkinson's disease. Mov Disord 2002;17:368.
50. Arnulf I, Bonnet AM, Damier P, Bejjani BP, Seilhean D, Derenne JP, Agid Y. Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis. Neurology 2000;55:281-8.
51. Boeve BF, Silber MH, Ferman TJ. REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 2004;17:146-57.
52. Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 2001;16:622-30.
53. Eisensehr I, von Lindeiner H, Jager M, Noachtar S. REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson's disease: is there a need for polysomnography? J Neurol Sci 2001;186:7-11.
54. Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus FJ, Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder -comparison with Parkinson's disease and controls. Brain 2000;123: 1155-60.
55. Rye DB, Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 2002;58:341-6.
56. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004;318:121-34.
57. Abbott RD, Ross GW, White LR, Tanner CM, Nelson JS, Petrovitch H. Excessive daytime sleepiness and the future risk of Parkinson's disease. Mov Disord 2005;20:S101.
58. Fronczek R, Overeem S, Lee S, et al. Hypocretin (orexin) loss in Parkinson's disease. Brain 2007;130:1586-95.
59. Druout X, Moutereau S, Nguyen JP, et al. Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology 2003;61:540-3.
60. Baumann C, Ferini-Strambi L, Waldvogel D, Werth E, Bassetti CL. Parkinsonism with excessive daytime sleepiness-A narcolepsy-like disorder? J Neurol 2005;252:139-45.
61. Arnulf I. Excessive daytime sleepiness in parkinsonism. Sleep Med Rev 2005;9:185-200.
62. Jenkinson C, Peto V, Fitzpatrick R, et al. Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the Short-form Health Survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39). Age Ageing 1995;24:505-9.
63. Jenkinson C, Peto V, Fitzpatrick R, Greenhall R, Hyman N. The parkinson's disease questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 1997;26:353-7.
64. Morrish P. Quality of Life in Parkinsons Disease. Parkinsons Disease 2002;4(1):1-3.
65. Karlsen K H, Larsen J P, Tandberg E, et al. Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 66:431-5.
66. Boczarska-Jedynak M, Opala G. Sleep disturbances in Parkinson's disease. Neurologia i Neurochirugia Polska 2005; 39(5):380-88.
67. Scaravilli T, Gasparoli E, Rinaldi F, Polesello G, Bracco F. Health related quality of life and sleep disorders in Parkinson's disease. Neurological Sci 2003;24(3):209-10.
68. Weintraub D, Moberg PJ, Duda JE, et al. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. J Am Geriatr Soc 2004;52(5):784-8.
69. Comella C. Sleep disturbances and excessive daytime sleepiness in Parkinson's disease: an overview. J Neural Trans 2006;70:349-55.
70. Korczyn AD. Autonomic nervous system disturbances in Parkinson's disease. In: Advances in Neurology: Parkinson's Disease: Anatomy, Pathology and Therapy, vol. 53. Edited by Streifler MB, Korczyn AD, Melamed E, Youdim MB. Raven Press: New York, 1990: pp. 463-8.
71. Sanford IR. Tolerance of debility in elderly dependents by supports at home: its significance for hospital practice. Br Med J 1975;3:471-3.
72. Pollack CP, Perlick D. Sleep problems and institutionalization of the elderly. J Geriatr Psychiatry Neurol 1991;4:204-10.
73. Happe S, Berger K. The association between caregiver burden and sleep disturbances in partners of patients with Parkinson's disease. Age Ageing 2002;31(5):349-54.
74. Crabb L. Sleep disorders in Parkinson's disease: the nursing role. Br J Nurs 2001;10(1):42-7.
75. Boeve BF, Silber MH, Ferman TJ. REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 2004;17(3):146-57.
76. Chaudhuri KR, Ellis C, Love-Jones S, Thomaides T,Clift S, Mathias CJ, Parkes JD. Postprandial hypotension and parkinsonian state in Parkinson's disease. Mov Disord 1997;12(6):877-84.
77. Buysse DJ, Reynolds CF III, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
78. Marinus J, Visser M, van Hilten JJ, Lammers GJ, Stiggelbout AM. Development of a questionnaire for sleep and sleepiness in Parkinson's disease. Sleep 2003;26:1049-1054.
79. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540-5.
80. Marinus J, Visser M, Partinez-Martin P, et al. A short psychosocial questionnaire for patients with Parkinson's Disease: the SCOPA-PS. J Clin Epidemiol 2003:56: 61-7.
81. De Boer AG, Wijker W, Speelman JD, De Haes JC. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 2002;158:41-50.
82. Marinus J, Visser M, van Hilten JJ, et al. Assessment of sleep and sleepiness in Parkinson disease. Sleep 2003;26:1049-54.
83. Schrag A, Selai C, Jahanshahi M, Quinn NP. The EQ-5D-A generic quality of life measure is an useful instrument to measure quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2000;69:67-73.
84. Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J; Parkinson Study Group. Development and testing of the Parkinson's disease quality of life scale. Mov Disord 2003;18:637-45.
85. Grosset D, Taurah L, Burn DJ, et al. A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis. J Neurol Neurosurg Psychiatry 2007;78:465-9.
86. Martinez-Martin P, O'Brien C. Extending levodopa action: COMT inhibition. Neurology 1998;50:527-32.
87. Block G, Liss C, Reines S, et al .Comparison of immediate release and controlled release carbidopa/Levodopa in Parkinson's disease. A multicentre 5 year study.Eur Neurol 1997;37:23-7.
88. Parkinson Study Group. Pramipexole versus levodopa as initial treatment for Parkinson's disease. A 4 year randomised controlled trial. Arch Neurol 2004;61:1044-53.
89. Biglan KM, Schwid S, Eberly S, et al.Rasagiline improves quality of life in patients with early Parkinson's disease. Mov Disord 2006;21(5):616-23.
90. Giladi N, Boroojerdi B. Rotigotine transdermal patch for 24 h can improve sleep quality in patients with Parkinson's disease: report from two open label trials. Eur J Neurol 2006;13(suppl 2):321.
91. Hogl B, Saletu B, Brandauer E, et al. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double blind, randomised, crossover, placebo controlled, polygraphic trial. Sleep 2002;25(8):905-9.
92. Grosset D. The rotigotine transdermal patch may provide continuous dopaminergic stimulation in early-stage Parkinson's disease. Adv Clin Neurol Rehab 2006; 6(2):32-4.
93. Hjort N, Ostergaard K, Dupont E. Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus. Mov Disord 2004;19:196-9.
94. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. NEJM 2006;355:896-908.